Drug Type Small molecule drug |
Synonyms CMND-100/Palmitoylethanolamide |
Action modulators, antagonists, agonists |
Mechanism 5-HT1A receptor modulators(Serotonin 1a (5-HT1a) receptor modulators), 5-HT2A receptor modulators(Serotonin 2a (5-HT2a) receptor modulators), 5-HT2B receptor antagonists(Serotonin 2b (5-HT2b) receptor antagonists) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H37NO2 |
InChIKeyHXYVTAGFYLMHSO-UHFFFAOYSA-N |
CAS Registry544-31-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alcohol Use Disorder | Preclinical | Canada | - | |
Alcohol Use Disorder | Preclinical | Canada | - |